| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 06/08/2004 | US6746989 Substituted benzoylpyrazoles as herbicides |
| 06/08/2004 | US6746731 Ferroelectric active matrix displays with wide operating temperature range |
| 06/03/2004 | WO2004046236A1 Thermally stabilised pvc compositions |
| 06/03/2004 | WO2004046119A1 Substituted aralkyl derivatives |
| 06/03/2004 | WO2004046101A2 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication |
| 06/03/2004 | WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring |
| 06/03/2004 | WO2004045500A2 Process for synthesizing antifolates |
| 06/03/2004 | WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
| 06/03/2004 | WO2004011005A3 Antimicrobial 2, 4-diamino-pteridine derivatives |
| 06/03/2004 | WO2003084937A3 Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases |
| 06/03/2004 | WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase |
| 06/03/2004 | US20040106782 Dye and ink jet printing ink |
| 06/03/2004 | US20040106753 C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 06/03/2004 | US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106631 Spirocondensed quinazolinones and their use as phosphodiesterase inhibitors |
| 06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant |
| 06/03/2004 | US20040106606 Dihydropyrones with tethered heterocycles |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106007 Electroluminescent iridium compounds with fluorinated phenylpryidines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/03/2004 | US20040104146 C-nitrosoaniline compounds and their blends as polymerization inhibitors |
| 06/03/2004 | DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| 06/03/2004 | CA2506503A1 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
| 06/03/2004 | CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication |
| 06/03/2004 | CA2506112A1 Substituted aralkyl derivatives |
| 06/03/2004 | CA2506010A1 A method for deuteration of a heterocyclic ring |
| 06/02/2004 | EP1424382A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423370A1 Fxr nr1h4 nuclear receptor binding compounds |
| 06/02/2004 | EP1423362A1 New mandelic acid derivatives and their use as thrombin inhibitors |
| 06/02/2004 | EP1423351A2 Biphenylene compounds |
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | CN1501962A Azo compound and process of producing the same, amd novel compound and process of producing azo compounds using the same |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501917A Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same |
| 06/02/2004 | CN1501802A Novel use of pyrimidinyl phenylethylene sulfonamide derivative |
| 06/02/2004 | CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 06/02/2004 | CN1152023C Substituted polycyclic aryl and hetero aryl uracils as anticoagulant |
| 06/02/2004 | CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743754 A sulfonylurea and one or more surfactants comprising as structural element at least 10 alkylene oxide units. |
| 05/27/2004 | WO2004044046A2 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 05/27/2004 | WO2004043936A1 Plk inhibitors |
| 05/27/2004 | WO2004043935A1 Polymerizable compounds with quadruple hydrogen bond forming groups |
| 05/27/2004 | WO2004043926A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | WO2004043924A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | WO2004043362A2 Acyl guanidine compounds and use thereof |
| 05/27/2004 | WO2003039549A3 Selective antibacterial agents |
| 05/27/2004 | US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections |
| 05/27/2004 | US20040102629 Thioquinazolinone derivatives and combinatorial libraries thereof |
| 05/27/2004 | US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/27/2004 | US20040102512 Statins reduce or repress T-lymphocyte activation mediated by MHC class II or CD40; new target is alternative to cytokine inhibitors |
| 05/27/2004 | US20040102465 Pesticides; insecticides; fungicides |
| 05/27/2004 | US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents |
| 05/27/2004 | US20040102463 Antiproliferative agents; anticancer agents; Erlotinib mesylate |
| 05/27/2004 | US20040102461 Synergistic mixture with anticancer drugs |
| 05/27/2004 | US20040102449 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers |
| 05/27/2004 | US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 05/27/2004 | US20040102436 Heterocyclic compound derivatives and medicines |
| 05/27/2004 | CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/27/2004 | CA2513493A1 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 05/27/2004 | CA2505361A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist |
| 05/27/2004 | CA2504766A1 2-pyridone derivatives as inhibitors of neutrophile elastase |
| 05/26/2004 | EP1422553A1 Improved base precursors for use in a photothermographic element |
| 05/26/2004 | EP1421634A2 Organic electroluminescent device based on 2,5-diaminoterephthalic acid derivatives |
| 05/26/2004 | EP1421105A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 05/26/2004 | EP1421069A1 Process for the preparation of cyclopenta[g]quinazoline derivatives |
| 05/26/2004 | EP1420784A1 Compounds effecting glucokinase |
| 05/26/2004 | EP1420644A1 Substituted propargylamines |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1117652B1 Tan-1057 derivatives |
| 05/26/2004 | EP1005445B1 N-alkanoylphenylalanine derivatives |
| 05/26/2004 | EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists |
| 05/26/2004 | EP0740650B1 Codrugs as a method of controlled drug delivery |
| 05/26/2004 | CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases |
| 05/26/2004 | CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods |
| 05/26/2004 | CN1151155C 1,5-dihydro-pyrazolo [3,4-D]-pyrimidinone derivatives |
| 05/26/2004 | CN1151140C Glucokinase activators |
| 05/26/2004 | CN1151137C Method of producing thiobarbituric acid derivatives |
| 05/26/2004 | CN1151132C Process for production of 2-pyridylpyridine derivatives |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/21/2004 | WO2004041817A1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 05/21/2004 | WO2004041810A1 Compounds useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | WO2004041790A1 Substituted quinazolines as antiviral agents, especially against cytomegaloviruses |
| 05/21/2004 | WO2004041789A1 Compositions useful as inhibitors of jak and other protein kinases |
| 05/21/2004 | WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 05/21/2004 | WO2004041755A2 Quinazolinone compounds as calcilytics |
| 05/21/2004 | WO2004041285A1 Antiinflammation agents |
| 05/21/2004 | WO2004041264A1 2-oxo-ethanesulfonamide derivates |
| 05/21/2004 | WO2004028452A3 Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents |
| 05/21/2004 | WO2004018473A3 Azapurine derivatives |
| 05/21/2004 | WO2003097614A3 Process for the preparation of rosuvastatin |